Table: begin end state 1 26 cytoplasmic 27 45 transmembrane 46 65 non-cytoplasmic 66 84 transmembrane 85 95 cytoplasmic 96 114 transmembrane 115 118 non-cytoplasmic 119 143 transmembrane 144 155 cytoplasmic 156 179 transmembrane 180 184 non-cytoplasmic 185 203 transmembrane 204 245 cytoplasmic 246 268 transmembrane 269 285 non-cytoplasmic 286 309 transmembrane 310 320 cytoplasmic 321 339 transmembrane 340 344 non-cytoplasmic 345 367 transmembrane 368 376 cytoplasmic 377 400 transmembrane 401 406 non-cytoplasmic 407 431 transmembrane 432 439 cytoplasmic
Input: >17727 FitnessBrowser__Keio:17727 MLPFLKAPADAPLMTDKYEIDARYRYWRRHILLTIWLGYALFYFTRKSFNAAVPEILANG VLSRSDIGLLATLFYITYGVSKFVSGIVSDRSNARYFMGIGLIATGIINILFGFSTSLWA FAVLWVLNAFFQGWGSPVCARLLTAWYSRTERGGWWALWNTAHNVGGALIPIVMAAAALH YGWRAGMMIAGCMAIVVGIFLCWRLRDRPQALGLPAVGEWRHDALEIAQQQEGAGLTRKE ILTKYVLLNPYIWLLSFCYVLVYVVRAAINDWGNLYMSETLGVDLVTANTAVTMFELGGF IGALVAGWGSDKLFNGNRGPMNLIFAAGILLSVGSLWLMPFASYVMQATCFFTIGFFVFG PQMLIGMAAAECSHKEAAGAATGFVGLFAYLGASLAGWPLAKVLDTWHWSGFFVVISIAA GISALLLLPFLNAQTPREA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server